Header

UZH-Logo

Maintenance Infos

Browse by Creators

Navigate back| Up a level
Export as
Number of items: 25.

Marquardt, L; Lacour, M; Hoernes, M; Opitz, L; Lecca, R; Volkmer, B; Reichenbach, J; Hohl, D; Ansari, M; Ozsahin, H; Güngör, T; Pachlopnik Schmid, J (2017). Unusual dermatological presentation and immune phenotype in SCID due to an IL7R mutation: the value of whole-exome sequencing and the potential benefit of newborn screening. Journal of the European Academy of Dermatology and Venerology, 31(3):e147-e148.

Marschall, K; Hoernes, M; Bitzenhofer-Grüber, M; Jandus, P; Duppenthaler, A; Wuillemin, W A; Rischewski, J; Boyman, O; Heininger, U; Hauser, T; Steiner, U; Posfay-Barbe, K; Seebach, J; Recher, M; Hess, C; Helbling, A; Reichenbach, J (2015). The Swiss National Registry for Primary Immunodeficiencies: report on the first 6 years' activity from 2008 to 2014. Clinical and Experimental Immunology, 182(1):45-50.

Brendel, C; Hänseler, Walther; Wohlgensinger, Vital; Bianchi, Matteo; Tokmak, Serap; Reichenbach, J; Seger, R; Siler, Ulrich (2013). Human miR223 promoter as a novel myelo-specific promoter for chronic granulomatous disease gene therapy. Human Gene Therapy. Methods, 24(3):151-159.

Bielas, H; Jud, A; Lips, U; Reichenbach, J; Landolt, M A (2012). Increased number of activated T cells in lymphocyte subsets of maltreated children: Data from a pilot study. Journal of Psychosomatic Research, 73(4):313-318.

Liu, L; Okada, S; Kong, X F; Kreins, A Y; Cypowyj, S; Abhyankar, A; Toubiana, J; Itan, Y; Audry, M; Nitschke, P; Masson, C; Toth, B; Flatot, J; Migaud, M; Chrabieh, M; Kochetkov, T; Bolze, A; Borghesi, A; Toulon, A; Hiller, J; Eyerich, S; Eyerich, K; Gulácsy, V; Chernyshova, L; Chernyshov, V; Bondarenko, A; Grimaldo, R M C; Blancas-Galicia, L; Beas, I M M; Roesler, J; Magdorf, K; Engelhard, D; Thumerelle, C; Burgel, P R; Hoernes, M; Drexel, B; Seger, R; Kusuma, T; Jansson, A F; Sawalle-Belohradsky, J; Belohradsky, B; Jouanguy, E; Bustamante, J; Bué, M; Karin, N; Wildbaum, G; Bodemer, C; Lortholary, O; Fischer, A; Blanche, S; Al-Muhsen, S; Reichenbach, J; Kobayashi, M; Rosales, F E; Lozano, C T; Kilic, S S; Oleastro, M; Etzioni, A; Traidl-Hoffmann, C; Renner, E D; Abel, L; Picard, C; Maródi, L; Boisson-Dupuis, S; Puel, A; Casanova, J L (2011). Gain-of-function human STAT1 mutations impair IL-17 immunity and underlie chronic mucocutaneous candidiasis. Journal of Experimental Medicine, 208(8):1635-1648.

Grez, M; Reichenbach, J; Schwäble, J; Seger, R; Dinauer, M C; Thrasher, A J (2011). Gene therapy of chronic granulomatous disease: the engraftment dilemma. Molecular Therapy, 19(1):28-35.

Hoernes, M; Seger, R; Reichenbach, J (2011). Modern management of primary B-cell immunodeficiencies. Pediatric Allergy and Immunology, 22(8):758-769.

Audry, M; Ciancanelli, M; Yang, K; Cobat, A; Chang, H H; Sancho-Shimizu, V; Lorenzo, L; Niehues, T; Reichenbach, J; Li, X X; Israel, A; Abel, L; Casanova, J L; Zhang, S Y; Jouanguy, E; Puel, A (2011). NEMO is a key component of NF-κB- and IRF-3-dependent TLR3-mediated immunity to herpes simplex virus. Journal of Allergy and Clinical Immunology, 128(3):610-617.

Nakagawa, N; Imai, K; Kanegane, H; Sato, H; Yamada, M; Kondoh, K; Okada, S; Kobayashi, M; Agematsu, K; Takada, H; Mitsuiki, N; Oshima, K; Ohara, O; Suri, D; Rawat, A; Singh, S; Pan-Hammarström, Q; Hammarström, L; Reichenbach, J; Seger, R; Ariga, T; Hara, T; Miyawaki, T; Nonoyama, S (2011). Quantification of κ-deleting recombination excision circles in Guthrie cards for the identification of early B-cell maturation defects. Journal of Allergy and Clinical Immunology, 128(1):223-225.e2.

Bianchi, M; Niemiec, M J; Siler, U; Urban, C F; Reichenbach, J (2011). Restoration of anti-Aspergillus defense by neutrophil extracellular traps in human chronic granulomatous disease after gene therapy is calprotectin-dependent. Journal of Allergy and Clinical Immunology, 127(5):1243-1252.

Schimke, L F; Sawalle-Belohradsky, J; Roesler, J; Wollenberg, A; Rack, A; Borte, M; Rieber, N; Cremer, R; Maass, E; Dopfer, R; Reichenbach, J; Wahn, V; Hoenig, M; Jansson, A F; Roesen-Wolff, A; Schaub, B; Seger, R; Hill, H R; Ochs, H D; Torgerson, T R; Belohradsky, B H; Renner, E D (2010). Diagnostic approach to the hyper-IgE syndromes: immunologic and clinical key findings to differentiate hyper-IgE syndromes from atopic dermatitis. Journal of Allergy and Clinical Immunology, 126(3):611-617.e1.

Kieslich, M; Hoche, F; Reichenbach, J; Weidauer, S; Porto, L; Vlaho, S; Schubert, R; Zielen, S (2010). Extracerebellar MRI-lesions in ataxia telangiectasia go along with deficiency of the GH/IGF-1 axis, markedly reduced body weight, high ataxia scores and advanced age. Cerebellum, 9(2):190-197.

Meissner, F; Seger, R A; Moshous, D; Fischer, A; Reichenbach, J; Zychlinsky, A (2010). Inflammasome activation in NADPH oxidase defective mononuclear phagocytes from patients with chronic granulomatous disease. Blood, 116(9):1570-1573.

Jürgens, B; Fuchs, D; Reichenbach, J; Heitger, A (2010). Intact indoleamine 2,3-dioxygenase activity in human chronic granulomatous disease. Clinical Immunology, 137(1):1-4.

Wohlgensinger, V; Seger, R; Ryan, M D; Reichenbach, J; Siler, U (2010). Signed outside: a surface marker system for transgenic cytoplasmic proteins. Gene Therapy, 17(10):1193-1199.

He, B; Santamaria, R; Xu, W; Cols, M; Chen, K; Puga, I; Shan, M; Xiong, H; Bussel, J B; Chiu, A; Puel, A; Reichenbach, J; Marodi, L; Döffinger, R; Vasconcelos, J; Issekutz, A; Krause, J; Davies, G; Li, X; Grimbacher, B; Plebani, A; Meffre, E; Picard, C; Cunningham-Rundles, C; Casanova, J L; Cerutti, A (2010). The transmembrane activator TACI triggers immunoglobulin class switching by activating B cells through the adaptor MyD88. Nature Immunology, 11(9):836-845.

Reichenbach, J; Lopatin, U; Mahlaoui, N; Beovic, B; Siler, U; Zbinden, R; Seger, R A; Galmiche, L; Brousse, N; Kayal, S; Güngör, T; Blanche, S; Holland, S M (2009). Actinomyces in chronic granulomatous disease: an emerging and unanticipated pathogen. Clinical Infectious Diseases, 49(11):1703-1710.

Morinishi, Y; Imai, K; Nakagawa, N; et al; Reichenbach, J (2009). Identification of severe combined immunodeficiency by T-cell receptor excision circles quantification using neonatal guthrie cards. Journal of Pediatrics, 155(6):829-833.

Reichenbach, J. Novel genetic defects of innate immunity with susceptibility to mycobacterial disease. 2009, University of Zurich, Faculty of Medicine.

Bianchi, M; Hakkim, A; Brinkmann, V; Siler, U; Seger, R A; Zychlinsky, A; Reichenbach, J (2009). Restoration of NET formation by gene therapy in CGD controls aspergillosis. Blood, 114(13):2619-2622.

Yousefi, S; Gold, J A; Andina, N; Lee, J J; Kelly, A M; Kozlowski, E; Schmid, I; Straumann, A; Reichenbach, J; Gleich, G J; Simon, H U (2008). Catapult-like release of mitochondrial DNA by eosinophils contributes to antibacterial defense. Nature Medicine, 14(9):949-953.

Reichenbach, J; Van de Velde, H; De Rycke, M; Staessen, C; Platteau, P; Baetens, P; Güngör, T; Ozsahin, H; Scherer, F; Siler, U; Seger, R A; Liebaers, I (2008). First successful bone marrow transplantation for X-linked chronic granulomatous disease by using preimplantation female gender typing and HLA matching. Pediatrics, 122(3):e778-e782.

Reichenbach, J; von Bernuth, H (2008). Genetisch bedingte Defekte der angeborenen Immunität - Erhöhte Anfälligkeit für mykobakterielle Infektionen, für invasive bakterielle Infektionen und für Herpes-simplex-Enzephalitis. Kinder- und Jugendmedizin, 8(3):171-178.

de Beaucoudrey, L; Puel, A; Filipe-Santos, O; Cobat, A; Ghandil, P; Chrabieh, M; Feinberg, J; von Bernuth, H; Samarina, A; Jannière, L; Fieschi, C; Stéphan, J L; Boileau, C; Lyonnet, S; Jondeau, G; Cormier-Daire, V; Le Merrer, M; Hoarau, C; Lebranchu, Y; Lortholary, O; Chandesris, M O; Tron, F; Gambineri, E; Bianchi, L; Rodriguez-Gallego, C; Zitnik, S E; Vasconcelos, J; Guedes, M; Vitor, A B; Marodi, L; Chapel, H; Reid, B; Roifman, C; Nadal, D; Reichenbach, J; Caragol, I; Garty, B Z; Dogu, F; Camcioglu, Y; Gülle, S; Sanal, O; Fischer, A; Abel, L; Stockinger, B; Picard, C; Casanova, J L (2008). Mutations in STAT3 and IL12RB1 impair the development of human IL-17-producing T cells. Journal of Experimental Medicine, 205(7):1543-1550.

Renner, E D; Rylaarsdam, S; Anover-Sombke, S; Rack, A L; Reichenbach, J; Carey, J C; Zhu, Q; Jansson, A F; Barboza, J; Schimke, L F; Leppert, M F; Getz, M M; Seger, R A; Hill, H R; Belohradsky, B H; Torgerson, T R; Ochs, H D (2008). Novel signal transducer and activator of transcription 3 (STAT3) mutations, reduced T(H)17 cell numbers, and variably defective STAT3 phosphorylation in hyper-IgE syndrome. Journal of Allergy and Clinical Immunology, 122(1):181-187.

This list was generated on Mon Dec 18 10:45:25 2017 CET.